Ventilator-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) Pneumonia in a Patient with a Negative MRSA Nasal Swab
American Journal of Case Reports · 2023
DOI: 10.12659/ajcr.941088 ↗Kurz gefasst
Fallbericht in der Zeitschrift American Journal of Case Reports, 2023. Verfasst von Michael Kalinoski und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hospital Medicine, Fairview Ridges Medical Center, Burnsville, MN, USA. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Pneumonia, Staphylococcal, Staphylococcal Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
BACKGROUND Methicillin-resistant Staphylococcus aureus (MRSA) pneumonia is associated with high morbidity and mortality. Recently, MRSA testing by nasal swab has been utilized to "exclude" pneumonia caused by MRSA, given its high negative-predictive value (NPV). We present, however, a case of MRSA pneumonia diagnosed by endotracheal aspirate culture (EAC) in a patient with a negative MRSA nasal swab. CASE REPORT A 58-year-old woman presented with septic shock and respiratory failure. Chest X-ray (CXR) on admission was unrevealing; however, computed tomography (CT) revealed multifocal pneumonia. Intensive Care Unit (ICU)-level care was required for mechanical ventilation and vasopressors. She initially improved with treatment of community-acquired pneumonia (CAP) and was extubated on hospital day 6; however, she then developed a fever, tachycardia, and respiratory distress necessitating re-intubation later that day. Repeat CXR demonstrated a new left lower lobe infiltrate. Blood cultures were drawn and vancomycin and cefepime were started to cover for ventilator-associated pathogens. An EAC and nasal swab were collected to test for MRSA. The next day (day 7), the MRSA nasal swab returned negative, and vancomycin was discontinued. Our patient continued to experience fevers, worsening leukocytosis, and ongoing vasopressor need. On hospital day 9, the EAC results were obtained, and were positive for MRSA. Vancomycin was restarted and our patient recovered. CONCLUSIONS Negative MRSA nasal screening may be considered grounds to de-escalate empiric MRSA antibiotics if MRSA prevalence is low. However, in critically ill patients with high risk and suspicion for MRSA pneumonia, discontinuing empiric MRSA coverage should be done with caution or clinicians should wait until respiratory culture results are obtained before de-escalating antibiotics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Hospital Medicine, Fairview Ridges Medical Center, Burnsville, MN, USA.
- Division of Pulmonary and Critical Care, Department of Medicine, University of Minnesota Medical Center, Minneapolis, MN, USA.
ORCID-Profile: Nicholas E Ingraham
Förderung
- NHLBI NIH HHS
Zitieren
APA
Kalinoski, M., & Ingraham, N. E. (2023). Ventilator-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) Pneumonia in a Patient with a Negative MRSA Nasal Swab. American Journal of Case Reports. https://doi.org/10.12659/ajcr.941088
Vancouver
Kalinoski M, Ingraham NE. Ventilator-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) Pneumonia in a Patient with a Negative MRSA Nasal Swab. American Journal of Case Reports. 2023. doi:10.12659/ajcr.941088
BibTeX
@article{Kalinoski2023,
author = {Kalinoski, Michael and Ingraham, Nicholas E},
title = {Ventilator-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) Pneumonia in a Patient with a Negative MRSA Nasal Swab},
journal = {American Journal of Case Reports},
year = {2023},
doi = {10.12659/ajcr.941088}
}
EUVIMED